RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-5586
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_0818100; Gene model (P.falciparum): PF3D7_0917100; Gene product: N-glycosylase/DNA lyase, putative (OGG1; PbOgg1)
Phenotype Liver stage;
Last modified: 29 November 2024, 12:41
  *RMgm-5586
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption
Reference (PubMed-PMID number) Reference 1 (PMID number) : 38964640
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherTiwari A, Habib S
Name Group/DepartmentDivision of Biochemistry and Structural Biology
Name InstituteCSIR-Central Drug Research Institute
CityLucknow
CountryIndia
Name of the mutant parasite
RMgm numberRMgm-5586
Principal namePbOgg1 KO
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot tested
Fertilization and ookineteNot tested
OocystNot different from wild type
SporozoiteNot different from wild type
Liver stageReduced infectivity of PbOgg1 KO sporozoites in C57BL/6 mice.
The patency (time between inoculation of sporozoites and appearance of parasites in blood) was prolonged (1.5 to 2 day delay) in PbOgg1 KO sporozoite-injected mice. PbOgg1 KO EEFs develop and mature into hepatic merozoites normally. Mice inoculated with PbOgg1 KO merosomes showed a substantial delay in patency (time for appearance of parasite blood stages) of approximately 2 days. This indicates that PbOgg1 KO merosomes are released efficiently from infected hepatocytes, but they are less infective to red blood cells.
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of pbOGG1

Protein (function)
Base excision repair (BER) DNA N-glycosylase Plasmodium homologs EndoIII and Ogg1would putatively recognize DNA lesions prior to the action of apurinic/apyrimidinic (AP)-endonucleases. Both Ape1 and Apn1 endonucleases have earlier been shown to function solely in the parasite mitochondrion.

Phenotype
Normal growth/multiplication of blood stage parasite. Normal oocyst and sporozoite production.
Reduced infectivity of PbOgg1 KO sporozoites in C57BL/6 mice. The patency (time between inoculation of sporozoites and appearance of parasites in blood) was prolonged (1.5 to 2 day delay) in PbOgg1 KO sporozoite-injected mice. PbOgg1 KO EEFs develop and mature into hepatic merozoites normally. Mice inoculated with PbOgg1 KO merosomes showed a substantial delay in patency (time for appearance of parasite blood stages) of approximately 2 days. This indicates that PbOgg1 KO merosomes are released efficiently from infected hepatocytes, but they are less infective to red blood cells.

Additional information
To attempt localisation of Ogg1 in P. berghei, a transgenic parasite line (PbOgg1-3XHA) was generated by tagging PbOgg1 with a C-terminal 3XHA (hemagglutinin) tag. The prepared tagging construct was transfected in cultured P. berghei schizonts. After successful transfection, integration of the tagging cassette was confirmed using a site-specific integration PCR. However, western blotting of the parasite lysate with antiHA Ab detected a protein band of the expected size only upon very high exposure, indicating that expression levels of the HA-tagged PbOgg1 were very low and could not be reliably used for localisation by IFA.

Other mutants


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0818100
Gene Model P. falciparum ortholog PF3D7_0917100
Gene productN-glycosylase/DNA lyase, putative
Gene product: Alternative nameOGG1; PbOgg1
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct used(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationTo disrupt PbOgg1, two fragments - F1 (0.54 kb) and F2 (0.57 kb) - encompassing the 5′ and 3′ untranslated regions (UTRs) were amplified using primers 1401/1402 and 1403/1404, respectively, and cloned in plasmid pBC-GFPhDHFR:yFCU. The integration cassette was released from the plasmid backbone by digestion with XhoI/AscI.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6